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Quantification of myocardial perfusion with 82Rb has been diffi-
cult to achieve because of the low signal-to-noise ratio of the
dynamic data curves. This study evaluated the accuracy of flow
estimates after the application of a novel multidimensional
wavelet-based noise-reduction protocol. Methods: Myocardial
perfusion was estimated using 82Rb and a two-compartment
model from dynamic PET scans on 11 healthy volunteers at rest
and after hyperemic stress with dipyridamole. Midventricular
planes were divided into eight regions of interest, and a wavelet
transform protocol was applied to images and time–activity
curves. Flow estimates without and with the wavelet approach
were compared with those obtained using H215O. Results: Over
a wide flow range (0.45–2.75 mL/g/min), flow achieved with the
wavelet approach correlated extremely closely with values ob-
tained with H215O (y 5 1.03 3 20.12; n 5 23 studies, r 5 0.94,
P , 0.001). If the wavelet noise-reduction technique was not
used, the correlation was less strong (y 5 1.11 3 1 0.24; n 5 23
studies, r 5 0.79, P , 0.001). In addition, the wavelet approach
reduced the regional variation from 75% to 12% and from 62%
to 11% (P , 0.001 for each comparison) for resting and stress
studies, respectively. Conclusion: The use of a wavelet proto-
col allows near-optimal noise reduction, markedly enhances the
physiologic flow signal within the PET images, and enables
accurate measurement of myocardial perfusion with 82Rb in
human subjects over a wide range of flows.
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Quantification of myocardial perfusion is of paramount
importance for the detection of ischemic heart disease and
for the evaluation of therapeutic interventions. PET pro-
vides a noninvasive approach to quantify regional myocar-
dial perfusion and perfusion reserve because of its ability to
delineate the distribution of positron-emitting radionuclides
within the myocardium. PET has been shown to accurately
detect coronary artery disease with the cyclotron-produced
flow tracers 13NH3 (1) and H215O (2,3) as well as with
generator-produced 82Rb chloride (4,5) or 62Cu-pyruvalde-
hyde bis(N 4-methylthiosemicarbazone) (6).
82Rb is an attractive flow tracer because it is generator
produced and has a short physical half-life (t1/2, 76 s). The
use of 82Rb obviates the necessity of a cyclotron and re-
duces the time to perform sequential imaging in patient
studies. Cardiac PET with 82Rb has been used widely in
clinical settings to diagnose coronary artery disease and to
assess qualitatively the severity of coronary stenosis. Visual
analysis of myocardial images has been reported to have a
sensitivity of 87% and a specificity of 88% (7). However,
accurate quantification of regional myocardial perfusion in
absolute terms (i.e., mL/g/min) using PET and 82Rb has
been difficult to achieve because of the complex behavior of
this tracer in the myocardium (5). Similar to other cationic
tracers (e.g., 13NH3), 82Rb is partially extracted by the
myocardium during a single capillary pass (8), but the
extraction fraction varies inversely and nonlinearly with
flow (9,10). Herrero et al. (5) measured myocardial perfu-
sion in dogs using the relationship between flow and ex-
traction fraction empirically derived from the experimental
results of Goldstein et al. (11) and Mullani et al. (9,10). This
approach was found to be insensitive to hyperemic flows
.2 mL/g/min and may not be accurate for regions with
prolonged ischemia or reperfusion (4). However, even when
flow and extraction fraction were decoupled directly using a
compartment model, estimates of blood flow were not ac-
curate at hyperemic flows, and regional variation was high
(5). Therefore, the quantification of myocardial perfusion
with 82Rb and dynamic PET in absolute terms has been
limited.
The goal of this study was to evaluate the effect of using
a wavelet-based noise-reduction protocol on improving the
signal-to-noise ratio of time–activity curves derived from
dynamic PET images with 82Rb and, consequently, on im-
proving the accuracy of quantification of myocardial perfu-
sion with this tracer.
The wavelet transform is a newly developed signal-pro-
cessing tool that decomposes a signal into different levels of
resolution. A wavelet is a small wave that can be used to
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represent simultaneously the time and frequency compo-
nents of a signal. Wavelet-based noise reduction has the
characteristics of optimally separating signal and noise,
preserving the rapid rises and falls of a signal, and recon-
structing a smooth signal from noise-imposed observations.
Although the short half-life of 82Rb is an attractive factor in
reducing the time to acquire sequential scans, it also results
in images with low signal-to-noise ratios. Thus, blood and
myocardial time–activity curves are disrupted by inherent
noise. Wavelet-based noise reduction provides a potential
approach to objectively restore the true signal hidden within
multidimensional images and therefore to enable accurate




This study was approved by the institutional review board of the
Columbia-Presbyterian Medical Center. Informed consent was ob-
tained. Eleven healthy volunteers (5 men, 6 women; mean age,
44 y; age range, 24–70 y) without a history of ischemic heart
disease were recruited. Seven subjects (3 men, 4 women) repeated
the same scanning protocol in the following month.
Tomographic Data Acquisition
Each subject was placed in an ECAT EXACT-47 whole-body
PET scanner (CTI/Siemens, Knoxville, TN). A transmission scan
using an external ring of 68Ge/68Ga was obtained for attenuation
correction. A dose of 82Rb (average, 0.01 MBq/kg) was infused
through an antecubital vein using the Bracco infusion system
(Bracco Diagnostics, Princeton, NJ). A 7-min emission scan was
acquired. After decay of radioactivity to background levels (82Rb
t1/2, 76 s), a bolus of H215O (average, 0.008 MBq/kg) was admin-
istered intravenously and a 5-min scan was obtained. The doses
were selected so that the system dead time was ,30%. All subjects
were then given 0.14 mg/kg/min dipyridamole intravenously over
4 min. Three minutes after the end of dipyridamole infusion, the
same sequence of emission scans with 82Rb and H215O was re-
peated (Fig. 1). Hemodynamic data, including heart rate, systolic
blood pressure, and diastolic blood pressure, were recorded at the
onset of the transmission scan, the beginning and end of each
emission scan, and each minute during dipyridamole infusion. The
sequence of scans was selected so that the shortest half-life tracer
(82Rb) was administered first and radioactivity had declined to near
background levels before administration of H215O.
Because of technical problems, such as generator failure and
adverse response to dipyridamole, some subjects did not complete
the scanning protocol. Thirteen successful pairs of 82Rb–H215O
studies at rest and 10 pairs at hyperemia (23 studies, total) were
obtained.
Analysis of Tomographic Data
Emission data obtained after administration of 82Rb were recon-
structed into thirty-six 5-s frames, eight 15-s frames, and four 30-s
frames (48 frames in 7 min). Data obtained after administration of
H215O were reconstructed into twenty-four 5-s frames, six 10-s
frames, and eight 15-s frames (38 frames in 5 min). The recon-
structed data were reoriented to short-axis images, and the contour
of the heart was delineated by the circumferential analysis (12).
Myocardial tissue in each midventricular plane was divided into
eight regions of interest (ROIs), each representing a volume of
0.70–0.85 cm3. Forty to 64 ROIs were analyzed for each subject
on the basis of the size of the heart (i.e., five to eight short-axis
planes per subject). The arterial blood time–activity curves, nec-
essary to define the input function, were selected from multiple
pixels located near the center of the left ventricular chamber from
basal slices. Forty to 64 ROIs were analyzed for each subject on
the basis of the size of the heart.
Quantification of Myocardial Perfusion Using 82Rb
Tissue and blood time–activity curves derived from dynamic
PET images obtained after administration of 82Rb were fitted to a
previously developed two-compartment model (5). Myocardial
perfusion was estimated for each ROI. This model estimates the
forward and the backward rates of transport (k1 and k2) between
the extracellular space and the intracellular space (Fig. 2). In
addition to flow, k1 and k2, blood-to-tissue spillover fraction (FBM)
was estimated by the fitting process. The recovery coefficient
(FMM) was set to 0.65, and the fractional volume of the first
compartment (Vd) was fixed at 0.75 mL/mL (5). For each subject,
values of each ROI were analyzed separately and also averaged to
get a global flow. The coefficient of variation (COV) (i.e., the
inverse of the ratio of the global flow to the associated SD) was
calculated. The approach used to quantify myocardial perfusion
with unmodified raw data was referred to as the original protocol.
Quantification of Myocardial Perfusion Using 82Rb
Through Wavelet-Based Noise Reduction
A wavelet-based noise-reduction protocol was designed to re-
store the underlying multidimensional signal hidden within noise-
imposed 82Rb data. The bases of the wavelet transform were a set
of spline-derived functions developed by Laine and Koren (13).
The noise-reduction algorithm proposed by Donoho and Johnstone
(14–16) and implemented by Lin et al. (17) for dynamic PET data
evaluated local signals in the wavelet domain and ensured a
near-optimal suppression of noise.
FIGURE 1. Imaging protocol. Each subject had a transmission scan followed by emission scans at rest with 82Rb and H215O.
Dipyridamole was infused to induce hyperemia. Another set of emission images was obtained starting 3–4 min after end of
dipyridamole administration.
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Each short-axis image of sequential 82Rb frames in each mid-
ventricular plane underwent a two-dimensional wavelet-based
noise reduction. The same ROIs were placed on the noise-sup-
pressed images according to the coordinates determined in the
circumferential analysis. The radioactivity in each ROI was aver-
aged, and a tissue time–activity curve was then created. The tissue
curves of adjacent ROIs on the same horizontal plane and those of
the vertical stacks represent the time-varying radioactivity of the
entire heart. The wavelet-based noise-suppression method was
then applied to the spatial domain and the temporal domain of
these dynamic curves to remove the noise that disrupted the
continuity among adjacent ROIs and among sequential frames.
After the multidimensional noise-suppression process, a recon-
structed tissue time–activity curve was created for each ROI. The
blood curve found in the original approach also underwent a
one-dimensional wavelet-based noise reduction. The blood curve
and tissue curves were then fitted to the two-compartment model
(Fig. 2) to obtain flow estimates.
Quantification of Myocardial Perfusion Using H215O
Tissue and blood time–activity data derived from dynamic PET
images obtained after administration of H215O were fitted to a
previously developed and validated one-compartment model (2,3).
Regional myocardial perfusion for each ROI was estimated. This
model also estimated the FMM and FBM (2,3). Quantification of
myocardial flow with H215O was used as a reference value, and
estimates obtained from dynamic images with 82Rb were compared
with those from H215O.
Statistics
A paired t test was used to compare hemodynamic data from the
82Rb scans and H215O scans and also differences before and after
pharmacologic stress. Pearson’s correlation was calculated be-
tween the global flows derived from H215O images and those
obtained with 82Rb. An F test was used to determine whether the
relationship between these two flow measurements differed signif-
icantly from the line of identity.
RESULTS
Hemodynamic Data of Subjects
The hemodynamic data for all subjects before and after
pharmacologic stress are shown in Table 1. Heart rate,
systolic blood pressure, diastolic blood pressure, and mean
arterial pressure did not differ between resting 82Rb and
H215O scans. Heart rate and systolic blood pressure in-
creased significantly after administration of dipyridamole.
The time between 82Rb and H215O administration after di-
pyridamole was 7–8 min. After dipyridamole, heart rate at
the beginning of 82Rb infusion was slightly higher (by 6
beats/min) than that at the time of injection of H215O (P ,
0.001) because of the delay between the two scans. Systolic,
diastolic, and mean arterial pressures did not differ.
Myocardial Images
The reconstructed midventricular short-axis images from
the last 30-s frame obtained in a healthy subject after the
administration of 82Rb before and after wavelet-based noise
reduction are shown in Figure 3. After the noise-reduction
maneuver, the contour of the left ventricle became clearer.
Time–Activity Data Before and After Wavelet-Based
Noise Reduction
Figure 4 shows 82Rb time–activity curves from an ROI of
a healthy volunteer studied at rest. The raw blood curve and
the tissue curve are noisy and deviate from theoretic shapes
FIGURE 2. Two-compartment model
describes kinetic behavior of 82Rb in
myocardium. Q1(t) and Q2(t) 5 82Rb activ-
ity in extracellular (intravascular and inter-
stitial) and intracellular spaces, respec-
tively; MBF 5 myocardial blood flow; k1
and k2 5 forward and backward rates of
transport between two compartments;
Vd 5 distribution volume of free 82Rb in
myocardium; FBM 5 spillover fraction
from myocardial blood pool to myocar-
dial tissue; Ca(t) 5 radioactivity in blood
pool.
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because of noise (Fig. 4A). Figure 4B shows the blood and
tissue time–activity curves of the same region after the
wavelet-based noise reduction.
Myocardial Blood Flow
The accuracy of the flow estimates obtained with 82Rb
before and after wavelet-based noise reduction was com-
pared with the reference values derived from H215O. Flow
derived from H215O studied at rest was 0.92 6 0.19 mL/g/
min. The corresponding resting flow obtained from 82Rb
studies was somewhat higher (1.15 6 0.46 mL/g/min) using
the original protocol and was slightly lower (0.82 6 0.26
mL/g/min) using the wavelet protocol. The correlation with
the reference values of H215O was 0.66 (P 5 0.014) and
0.92 (P , 0.001), respectively. The hyperemic flow derived
from H215O was 1.89 6 0.50 mL/g/min compared with
2.50 6 0.54 mL/g/min (r 5 0.28, P 5 0.418) derived from
82Rb studies before and 1.85 6 0.56 mL/g/min (r 5 0.82,
P 5 0.003) after wavelet-based noise reduction.
Figure 5 shows scatter plots of global flows obtained
from 82Rb and H215O combining resting and hyperemic
studies (n 5 23 studies). The linearity was poor when the
original protocol was used (Fig. 5A: y 5 1.11 3 1 0.24;
n 5 23, r 5 0.79, P , 0.001). Some data points are located
far above the regression line, indicating a poor correlation at
high flows. The correlation and linearity were significantly
improved after the wavelet protocol was applied (Fig. 5B:
y 5 1.03–0.12; r 5 0.94, P , 0.001).
An F test was used to evaluate whether these two mea-
surements yielded identical values (F 5 1.30; P . 0.05).
This indicates that wavelet-based quantification with 82Rb
and the reference value with H215O were statistically indis-
tinguishable. The corresponding Bland–Altman plots (Fig.
6) reveal the lack of bias and the reduction in the limits of
agreement after the wavelet protocol was applied.
The accuracy of the quantification with the application of
wavelet-based noise reduction on 82Rb images and dynamic




















































































































































































































































































































































































































































































































































































































































































































FIGURE 3. Myocardial short-axis images obtained from last
30-s frame after administration of 82Rb before (A) and after (B)
wavelet-based noise reduction. Contour of heart became
clearer and homogeneity of tissue counts increased after wave-
let processing.
204 THE JOURNAL OF NUCLEAR MEDICINE • Vol. 42 • No. 2 • February 2001
myocardial perfusion. Without the wavelet approach, the
COV of regional flow estimates was large, averaging
75% 6 34% among all of the resting studies (40–64 ROIs
per study; total ROIs, 560) and 62% 6 9% among all of the
hyperemic studies with 82Rb (40–64 ROIs per study; total
ROIs, 448) (Fig. 7). The corresponding COV obtained from
the one-compartment model with H215O was only 13% 6
3% and 17% 6 4% for resting and hyperemic studies,
respectively. The wavelet approach markedly reduced the
heterogeneity of regional flow estimates with 82Rb to a
value of 11% 6 3% for both the resting and the hyperemic
studies (P , 0.001) (Fig. 7).
DISCUSSION
PET has been used widely to evaluate coronary heart
disease and to determine the outcomes of therapeutic inter-
ventions (18). Quantification of myocardial perfusion by
dynamic PET imaging and kinetic models has provided an
objective means for measuring the severity and extent of
ischemic defects in absolute terms (19–21). The use of
13NH3 and H215O with dynamic PET scans has been vali-
dated to accurately measure myocardial flow in human
subjects (1–3). However, the preparation of these two flow
tracers requires an on-site cyclotron. Currently, 82Rb is the
only generator-produced tracer in clinical use for evaluating
myocardial perfusion (6). Use of 82Rb increases the flexi-
bility of PET by obviating the need for an on-site cyclotron;
its short physical half-life also allows rapid sequential scans
(6,22,23).
Accurate flow estimates using dynamic images and a
compartment model using 82Rb have been difficult to make
because of the sensitivity of the estimates to errors and noise
(23). With the original protocol, the differences between
flow estimates with 82Rb and those with H215O were large,
the variation in a normal heart was unacceptably high, and
the estimate-to-error ratio of each flow estimate was poor. In
addition, estimates with 82Rb became insensitive at high
flows (Fig. 5A). These results corroborate our previous
findings in animals (4,5). Initially, it was believed that the
lack of sensitivity at high flows was caused by a fixed
FIGURE 4. Blood (dotted line) and tis-
sue (solid line) time–activity curves of rep-
resentative ROI after administration of
82Rb before (A) and after (B) wavelet-
based noise reduction. Dynamic curves
became smoother, yet dynamics in early
frames were still preserved.
FIGURE 5. Correlation of global flow obtained from human subjects with H215O (x-axis) and 82Rb ( y-axis) combining resting and
hyperemic flows. (A) Original protocol with 82Rb before wavelet-based noise reduction. (B) After wavelet-based noise reduction.
Wavelet protocol improved correlation considerably over wide range of flows. MBF 5 myocardial blood flow; b0 5 intercept; b1 5
slope of line.
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relationship between flow and extraction fraction during the
fitting process. If this were the only reason, decoupling
these two parameters would have improved the accuracy of
flow estimates. However, a subsequent study that simulta-
neously estimated flow and rates of transport still revealed
significant residuals between flow estimates with 82Rb and
the reference values obtained with radiolabeled micro-
spheres (5).
The results of this study suggest that the failure to get
accurate flow estimates with dynamic PET images with
82Rb is associated with a low signal-to-noise ratio of dy-
namic data obtained from noisy images and a high error
propagation through the kinetic model. The tissue time–
activity curve before noise reduction (Fig. 4A) contained
fluctuations, the amplitudes of which were about 10%–25%
of the average radioactivity in the plateau portion. This
signal-to-noise ratio indicates the amount of uncertainty in
the observed dynamic curves. The uncertainty was further
augmented 5- to 20-fold through the compartment model.
Typically, with a point flow estimate of 1.0 mL/g/min, its
associated SE might be as high as 0.3–0.6 mL/g/min, sig-
nificant enough to hamper the accuracy of quantification.
The kinetic model used in this study contained two com-
partments and three physiologic parameters (flow, k1, and
k2). The complex structure of this model describes the
behavior of 82Rb in the myocardium but inevitably increases
the sensitivity of flow estimates to noise. Therefore, a prac-
tical approach should be targeted to reduce the noise of
dynamic curves. Selecting a large ROI is one of the intuitive
methods to reduce the uncertainty of dynamic data. Klein et
al. (24) found an inverse relationship between the region
size and the regional variation in a dynamic PET study
using 18F-FDG to measure cerebral glucose metabolism.
Herrero et al. (5) segmented ROIs as large as 3–5 cm3 in
canine hearts imaged with 82Rb because blood flow in
smaller ROIs could not be assessed accurately. Although the
use of larger ROIs increases the statistical stability of dy-
namic data, it also prevents detection of small regional
differences.
The multidimensional wavelet-based noise reduction
used in this study avoided this tradeoff. The wavelet ap-
proach not only maintained a small region size (0.70–0.85
cm3) but also faithfully restored the shape of time–activity
curves, enhanced the signal-to-noise ratio of dynamic data
(Fig. 4B), and improved the accuracy of flow estimates.
Although resting flow with 82Rb was slightly lower than the
reference value with H215O, the two measurements were
statistically identical (F 5 1.30; P . 0.05). However, the
slight bias may represent small differences in the current
82Rb model such as the fixed Vd or FMM or a limitation of
the denoising approach used.
The linearity and high correlation were preserved over
the flow range from 0.45 to 2.75 mL/g/min (Fig. 5B). The
lack of sensitivity at high flows with the original protocol
(Fig. 5A) actually resulted from the inherent noise that
tended to produce an overestimate. The hyperemic flows
derived from H215O and wavelet-denoised 82Rb data in this
study are lower than those reported in previous studies (3),
likely because of different age distributions (25,26).
FIGURE 6. Bland–Altman plots be-
tween global flows obtained from H215O
studies and 82Rb studies before (A) and
after (B) wavelet denoising. Plots show
reduction in bias and limits of agreement
after wavelet approach.
FIGURE 7. COVs, which represent regional variation of flow
estimates, were reduced significantly after wavelet process at
rest and after dipyridamole.
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The data presented are an average global flow for 40–64
ROIs per subject per scan (i.e., eight segments per short-axis
plane 3 five to eight planes per subject). All segments were
averaged to provide one global flow per subject per scan.
Although this may smooth the data by creating a global
average, as shown in Figure 7, the COV (i.e., the agreement
of flow from segment to segment) was high without noise
reduction and was reduced to levels that are quite acceptable
after noise reduction.
Although many smoothing and filtering methods have
been tried to restore underlying biologic signal hidden
within multidimensional PET images (27), the wavelet ap-
proach has multiple advantages over other conventional
approaches. First, the wavelet transform provides a built-in
local adaptivity. This characteristic successfully preserved
the rapid surge of the blood and tissue activity in the early
frames (Fig. 4B). Second, the multidimensional wavelet
protocol used took into account the geometric position of all
ROIs and the temporal relationship among sequential
frames and ensured that the reconstructed signal was as
smooth as the true underlying function. The common prac-
tice that applies kernels or Fourier filters to medical images
to improve image quality is an empiric approach, and the
best effect is determined visually (28). In contrast, the
algorithm for wavelet-based noise reduction has a mathe-
matic algorithm to find the near-optimal amount to smooth
and, therefore, is an objective approach.
The wavelet denoising approach reduced absolute flow
estimated with 82Rb. Although this could be interpreted as a
limitation of the wavelet approach, the fact that the denois-
ing process brought flow estimates with 82Rb into line with
those obtained with H215O suggests that the higher flows
obtained in unprocessed data were associated with noise.
However, underestimation of flow with the approach needs
to be evaluated more fully. Studies from our laboratory have
shown that wavelet processing does not affect flow esti-
mates with H215O or 13NH3 (29).
As noted above, hyperemic flows obtained with H215O
were lower in this study than those in our previous work.
The explanation for this is not clear. The healthy subjects in
this study were older than those in our previous work, and
we have shown that there is a blunted response in the elderly
to dipyridamole (25). Other possibilities include occult hy-
percholesterolemia in the healthy volunteers, which is
known to blunt the hyperemic response to vasodilatation
(30), or other methodological issues (difference PET cam-
era or model implementation). The delay between adminis-
tration of H215O after dipyridamole, though only 7–8 min,
could also lead to a drop-off in coronary flow; however, our
previous work (6) would suggest that flow after dipyrida-
mole is quite constant for at least 15 min.
CONCLUSION
The results of this study suggest that noninvasive quan-
tification using dynamic PET images with 82Rb accurately
measures myocardial perfusion if a multidimensional wave-
let-based protocol has appropriately removed noise in the
dynamic data. This approach can assess myocardial flow in
regions smaller than 1 cm3 to the accuracy of that achieved
with H215O. Therefore, 82Rb can be used to quantify myo-
cardial perfusion in human subjects. The wavelet approach
may be applicable to a wide variety of dynamic imaging
procedures.
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